Ashtekar Aniket Amol, Kasumbiwal Ajay H, Male Rohit H, Varsha Dope
This license
enables reusers to distribute, remix, adapt, and build upon the material in any
medium or format for noncommercial purposes only, and only so long as
attribution is given to the creator.
Dr Soumya Swaminathan is an internationally respected Indian Pediatrician, clinical scientist, and global health leader whose work has significantly shaped the understanding and management of Pediatric tuberculosis and infectious diseases. Born into an academically accomplished family, her early exposure to scientific inquiry and social responsibility strongly influenced her career path. She completed her medical education in India and pursued advanced training in the United States of America, developing expertise in clinical research and public health. Her scientific contributions at the National Institute for Research in Tuberculosis were instrumental in improving child-friendly diagnostics, optimising treatment regimens, and strengthening national policies for tuberculosis control. As the first Indian Chief Scientist of the World Health Organization, she played a critical role during the coronavirus disease pandemic by promoting evidence-based decisionmaking and countering scientific misinformation. Throughout her career, Dr Swaminathan has navigated challenges including gender bias, limited research infrastructure, and global health inequities. Her leadership, resilience, and commitment to ethical, data-driven healthcare continue to inspire young clinicians and researchers. This paper examines her contributions, struggles, and the broader lessons her journey offers to Pediatrics and global public health. Key Message: Dr Soumya Swaminathan’s scientific work bridges Pediatric clinical care and public health research, leading to improved diagnosis, management and policy for diseases affecting vulnerable children worldwide.
Kasumbiwal Ajay H., Male Rohit H., Varsha Dope, et al. Contribution of Soumya Swaminathan in Field of Pediatrics. Pediatr. Edu. Res. 2025; 13(2): 93-95.
This license
enables reusers to distribute, remix, adapt, and build upon the material in any
medium or format for noncommercial purposes only, and only so long as
attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| November 24, 2025 | December 29, 2025 | December 30, 2025 |
Monday 07 September 2026, 07:09:21 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | November 24, 2025 |
| Accepted | December 29, 2025 |
| Published | December 30, 2025 |
This license
enables reusers to distribute, remix, adapt, and build upon the material in any
medium or format for noncommercial purposes only, and only so long as
attribution is given to the creator.